The Effectiveness of Early Mobilization for Acute Ischemic Stroke Treated With Rt-PA or IA Thrombectomy
Stroke Center, Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
1 other identifier
interventional
122
1 country
1
Brief Summary
The purpose of the study will to test the hypothesis that combining early out-of-bed mobilization within 72 hours of stroke onset with treated by intravenous recombinant tissue-type plasminogen activator (IV-rtPA) or endovascular thrombectomy (ET) would result in a greater benefit than standard early rehabilitation within 72 hours of stroke onset with treated by IV-rtPA or ET.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2018
CompletedFirst Posted
Study publicly available on registry
September 21, 2018
CompletedStudy Start
First participant enrolled
October 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2022
CompletedNovember 30, 2022
August 1, 2022
5 days
September 20, 2018
November 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The total score-change of the Functional Independence Measure (FIM) assessment for daily living function
The total FIM with total score ranges from 13 to 126, which was used to assess each patient's capacities in terms of activities of daily living, comprises 18 seven-level items and assesses dependence in self-care, sphincter management, transfer, locomotion, communication, social interaction, and cognition. The functional independence of patient's capacities in terms of activity of daily living. Higher values represent a better outcome and all subscales are summed as a total score.
at baseline, at 2 weeks after stroke, at 4 weeks after stroke, and at follow-up 3 months after stroke
Secondary Outcomes (2)
The total score-change of the Postural Assessment Scale for Stroke Patients (PASS) assessment for postural stability
at baseline, at 2 weeks after stroke, at 4 weeks after stroke, and at follow-up 3 months after stroke
Achievement of the walking motor milestones
within 2 weeks after stroke
Other Outcomes (2)
Safety/Adverse event outcome
up to 4 weeks after stroke
the length of stay in the stroke center
within admission
Study Arms (2)
standard early rehabilitation
ACTIVE COMPARATORThe standard early rehabilitation program after acute stroke is an intervention regularly utilized in the stroke center of National Taiwan University Hospital.
adding early out-of-bed mobilization
EXPERIMENTALThe adding early out-of-bed mobilization treatment will be defined as the patients with acute ischemic stroke who receive out-of-bed mobilization treatment in addition to standard early rehabilitation care.
Interventions
The standard early rehabilitation program is an intervention regularly utilized in the stroke center of National Taiwan University Hospital. Activities performed in the standard early rehabilitation program within 24-72 hours of onset include(1) bed exercises including the joint range of motion exercise, bridge exercise, the straight leg raising exercise, stretching exercises, and facilitation techniques, and (2) functional training in which the patients are instructed to engage in the repetitive and systematic practice of tasks, such as rolling or sitting supported on the bed.
Early mobilization treatment involving out-of-bed, task-specific activities including rolling and sitting up, sitting unsupported out of bed, and standing within 24-72 hours of onset and accounting for more than two thirds of the treatment time in early rehabilitation .
Eligibility Criteria
You may qualify if:
- for experimental group: first ischemic stroke episode to receive either medical therapy (including intravenous thrombolysis using recombinant tissue-type plasminogen activator within 3 hours of onset) or endovascular therapy within 8 hours of onset (including intravenous thrombolysis following thrombectomy); for control group: first ischemic stroke episode to receive general medical therapy;
- completely activities of daily living independent before stroke;
- age above 20 years old;
- stroke with unilateral hemiparesis lesions confirmed using magnetic resonance imaging or computed tomography;
- no other peripheral or central nervous system dysfunction;
- no active inflammation or pathologic changes in the joints;
- no other active medical problems; and
- able to react to verbal commands, with systolic blood pressure between 120 and 160 mm Hg when resting, oxygen saturation \>92% (with or without supplementation), and a heart rate below 130 beats per minute when resting with temperature \<38.5 ℃
You may not qualify if:
- unstable vital sign;
- medical conditions unrelated to the cerebrovascular accident but which have affected walking performance;
- any other cognitive, emotional, or behavioral impairments resulting in insufficient comprehension, understanding, or collaboration;
- unable receive the informed consent form
- acute deterioration within 24 hours or symptomatic intracerebral hemorrhage defined by a parenchymal hemorrhage type 2 within 36 hours with an increase of 4 points or more in National Institute of Health Stroke Scale;
- acute hydrocephalus within 24 hours of onset
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiann-Shing Jeng, PhD
Stroke Center & Department of Neurology, National Taiwan University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 20, 2018
First Posted
September 21, 2018
Study Start
October 5, 2018
Primary Completion
October 10, 2018
Study Completion
June 10, 2022
Last Updated
November 30, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share